发明名称 PHARMACEUTICAL COMPOSITION
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a pharmaceutical composition containing hetero ring compound, which has excellent effects of suppressing collagen production and/or treating tumors. <P>SOLUTION: The pharmaceutical composition includes a compound represented by formula (1) [wherein R<SP>1</SP>is a group R<SP>5</SP>-Z<SB>1</SB>- or the like, Z<SB>1</SB>is a lower alkylene group or the like, R<SP>5</SP>is a group or the like, R<SP>13</SP>is a hydrogen atom or the like, R<SP>2</SP>is hydrogen atom or the like, Y is CH or N and A<SB>1</SB>is a heterocyclic ring like an indole-diyl group or the like, which heterocyclic ring may have one or more substituents. T is a group-CO- or the like, R<SP>3</SP>is a hydrogen atom or the like, R<SP>4</SP>is a lower alkyl group or the like which may have a hydroxyl group as a substituent, and R<SP>3</SP>and R<SP>4</SP>may bind to one another to form a 5 to 10-membered saturated heterocyclic ring together with nitrogen atom to which they bind], and its salt. <P>COPYRIGHT: (C)2011,JPO&INPIT</p>
申请公布号 JP2010275302(A) 申请公布日期 2010.12.09
申请号 JP20100102797 申请日期 2010.04.28
申请人 OTSUKA PHARMACEUT CO LTD 发明人 SUMITA TAKUMI;TAFUSA FUJIO;SEKIGUCHI KAZUO;KODAMA KENJI;YASUMURA KOICHI;KOJIMA YUTAKA;MOTOYAMA MASAAKI;MIYAJIMA KEISUKE;YOSHIDA KENJI;SUGA KEIZO;SAKAMOTO MAKOTO;TAKASU HIDEKI;NAKAGAWA TAKASHI;OI NAOTO;HARADA YASUO;HASHIMOTO NORIKAZU;MATSUYAMA HIRONORI;IIDA MASATOSHI;FUJITA SHIGEKAZU;FUKUSHIMA TAE
分类号 A61K31/496;A61K31/506;A61P1/16;A61P11/00;A61P13/12;A61P35/00;A61P35/02;A61P35/04;A61P43/00;C07D401/12;C07D401/14;C07D403/12;C07D405/14;C07D409/14;C07D513/04 主分类号 A61K31/496
代理机构 代理人
主权项
地址